Scientech Research’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRE
Scientech Research's SYRE Position: Q2 2026 in Review
Scientech Research sold out of Spyre Therapeutics (SYRE) in Q2 2026, closing a stake of 7,088 shares — an estimated $358K sold.
Scientech Research first reported a position in SYRE in Q1 2024 and held it in 2 quarters. The position peaked at $499K in Q1 2024. 266 funds tracked by Wall St. Rank hold SYRE as of Q2 2026.
- Scientech Research reported no remaining Spyre Therapeutics position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 7,088 Spyre Therapeutics shares in Q2 2026, an estimated $358K.
- Scientech Research first reported a position in Spyre Therapeutics in Q1 2024 and held it in 2 quarters.
- Scientech Research's Spyre Therapeutics position peaked at $499K in Q1 2024.
- 266 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.